M06.0 Rheumatoid arthritis without rheumatoid factor

Name of the Condition

• Rheumatoid arthritis without rheumatoid factor

Summary

Rheumatoid arthritis without rheumatoid factor (seronegative rheumatoid arthritis) is a chronic inflammatory disorder affecting joints, characterized by symmetric joint pain, swelling, and stiffness. It lacks detectable rheumatoid factor in blood tests, distinguishing it from seropositive rheumatoid arthritis. The condition can lead to joint damage and functional impairment over time.

Causes

The exact cause is unknown, but it involves an autoimmune response where the body’s immune system mistakenly attacks joint tissues. Genetic and environmental factors may contribute to disease development, though specific triggers remain unclear.

Risk Factors

• Genetic predisposition (e.g., HLA-DR4 alleles).
• Age: Typically onset between 30–50 years.
• Sex: More common in women.
• Smoking: Increases risk and disease severity.
• Family history of autoimmune diseases.

Symptoms

• Joint pain, swelling, and stiffness (especially in small joints of hands/feet).
• Symmetric joint involvement.
• Morning stiffness lasting >30 minutes.
• Fatigue and low-grade fever.
• Reduced range of motion.

Diagnosis

Diagnosis relies on clinical evaluation, including joint examination, symptom duration, and exclusion of other conditions. Blood tests check for inflammatory markers (e.g., ESR, CRP) and rule out rheumatoid factor. Imaging (X-rays, MRI) assesses joint damage. Criteria like the 2010 ACR/EULAR classification may guide diagnosis.

Treatment Options

• Medications: DMARDs (e.g., methotrexate), NSAIDs, and corticosteroids to reduce inflammation.
• Physical therapy to maintain joint function.
• Lifestyle modifications (e.g., exercise, weight management).
• Surgery (e.g., joint replacement) for severe damage.

Prognosis and Follow-Up

Prognosis varies; early treatment can slow progression. Regular follow-ups monitor disease activity, medication efficacy, and complications. Long-term management focuses on preserving joint function and quality of life.

Complications

• Joint deformity or destruction.
• Cardiovascular disease.
• Lung involvement (e.g., interstitial lung disease).
• Increased infection risk due to immunosuppressive therapies.

Lifestyle & Prevention

• Exercise to strengthen joints and improve mobility.
• Smoking cessation to reduce disease activity.
• Stress management and balanced diet.
• Regular monitoring for early detection of complications.

When to Seek Professional Help

Seek care if experiencing persistent joint pain, swelling, or stiffness lasting >6 weeks, or if symptoms worsen despite treatment. Urgent evaluation is needed for sudden severe pain, fever, or new neurological symptoms.

Tips for Medical Coders

Document clinical findings supporting seronegative status (e.g., negative rheumatoid factor tests) and joint involvement patterns. Ensure coding aligns with ICD-10-CM guidelines, specifying "without rheumatoid factor" to distinguish from seropositive variants. Include details on disease activity, treatment response, and complications for comprehensive coding.